New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 18, 2013
07:21 EDTJAZZJazz Pharmaceuticals price target raised to $87 from $76 at Lazard Capital
Lazard Capital raised its price target fort Jazz Pharmaceuticals citing expectations for robust Xyrem revenue growth and keeps a Buy rating on the stock.
News For JAZZ From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
August 24, 2015
18:55 EDTJAZZOn The Fly: After Hours Movers
Subscribe for More Information
18:52 EDTJAZZJazz, Celgene, Shire up after USPTO rejects Acorda patent challenge
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use